Authors, year | Age, sex | Malignancy | ICI | Doses prior to myocarditis | Treatments utilized | Outcome |
---|---|---|---|---|---|---|
Arangalage et al. (2017) | 35, F | Melanoma | Ipi 3 mg/kg, Nivo 1 mg/kg | 1 | Intravenous solumedrol 1 g/day and IVIG followed by ECMO and plasma exchange followed by tacrolimus | Survived |
Frigeri et al. (2018) | 76, F | Metastatic lung adenocarcinoma | Nivo (dose NA) | 7 | ECMO, IABP, intravenous methylprednisolone 5 mg/kg/day, plasmapheresis, infliximab 5 mg/kg, three doses | Survived |
Yamaguchi et al. (2018) | 60, M | Melanoma | Nivo 2 mg/kg | 13 | ECMO, IABP, intravenous prednisolone 1000 mg/day for 3 days + IVIG at 50 g/day for 2 days | Survived |
Imai et al. (2018) | 70, M | Squamous cell carcinoma of lung | Pembro (200 mg) | 2 | Intravenous methylprednisolone (1 g/day) for 3 days, IVIG 1 g/kg for 2 days, ECMO, IABP | Died |